OCC 1.32% 38.5¢ orthocell limited

Ann: Orthocell Appoints Exclusive Distributor in Australia, page-21

  1. 7,543 Posts.
    lightbulb Created with Sketch. 6810
    Nah, just a big sell down that looks done (big volume sold down at 3-3.10pm. An opportunity for some as it bounces back almost immediately. I am overloaded on OCC and from a risk perspective cannot really buy more. Roll on clarification on the FDA 510K trial pass talks and which direction they are taking in the US with Remplir (CelGro Nerve).

    Personally been waiting for the ATI vs Corticosteroid results for years now and can wait, having been a very successful beneficiary of ATI treatment. Obviously I'd like this to work for my investment, but its a crime ATI is not out there helping the millions of degenerative tendon injuries. I bet most people reading this have a nagging achilles, patellar, extensor, rotator cuff injury, etc...
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.